210 related articles for article (PubMed ID: 20619374)
1. Characterization and immune effect of the hepatitis B-BCG combined vaccine for using a needle innoculation.
Jin L; Wang G; Zhao X; Wang Z; Yang L; Yu A; Xu Y; Li W
Vaccine; 2010 Aug; 28(37):6041-51. PubMed ID: 20619374
[TBL] [Abstract][Full Text] [Related]
2. Immunogenicity and safety of combined intradermal recombinant Hepatitis B with BCG vaccines at birth.
Carniel EF; Morcillo AM; Blotta MH; Da Silva MT; Mazzola TN; Antonio MA; Zanolli ML; Netto AA; Higashi HG; Raw I; Vilela MM
Vaccine; 2008 Jan; 26(5):647-52. PubMed ID: 18155811
[TBL] [Abstract][Full Text] [Related]
3. Humoral and cellular immune responses to hepatitis B vaccination in hepatitis B surface antigen-carrier children who cleared serum-hepatitis B surface antigen.
Hsu HY; Chang MH; Hsieh RP; Ni YH; Chi WK
Hepatology; 1996 Dec; 24(6):1355-60. PubMed ID: 8938161
[TBL] [Abstract][Full Text] [Related]
4. [Comparison of the kinesis of immune responses in mice vaccinated by different kinds of recombinant hepatitis B vaccines].
Hu ZY; He P; Fang X; Qiu SH; Liang ZL; Li HM; Zhuang H
Zhonghua Liu Xing Bing Xue Za Zhi; 2008 Aug; 29(8):810-4. PubMed ID: 19103120
[TBL] [Abstract][Full Text] [Related]
5. Humoral response and genetic stability of recombinant BCG expressing hepatitis B surface antigens.
Rezende CA; De Moraes MT; De Souza Matos DC; McIntoch D; Armoa GR
J Virol Methods; 2005 Apr; 125(1):1-9. PubMed ID: 15737410
[TBL] [Abstract][Full Text] [Related]
6. Quantitation of group-specific a antigen in hepatitis B vaccines by anti-HBs/a monoclonal antibody.
Yamamoto H; Satoh T; Kiyohara T; Totsuka A; Moritsugu Y
Biologicals; 1997 Dec; 25(4):373-80. PubMed ID: 9467033
[TBL] [Abstract][Full Text] [Related]
7. Waning immunity to plasma-derived hepatitis B vaccine and the need for boosters 15 years after neonatal vaccination.
Lu CY; Chiang BL; Chi WK; Chang MH; Ni YH; Hsu HM; Twu SJ; Su IJ; Huang LM; Lee CY
Hepatology; 2004 Dec; 40(6):1415-20. PubMed ID: 15565627
[TBL] [Abstract][Full Text] [Related]
8. Humoral and cellular immune responses to a hepatitis B vaccine booster 15-18 years after neonatal immunization.
Lu CY; Ni YH; Chiang BL; Chen PJ; Chang MH; Chang LY; Su IJ; Kuo HS; Huang LM; Chen DS; Lee CY
J Infect Dis; 2008 May; 197(10):1419-26. PubMed ID: 18444799
[TBL] [Abstract][Full Text] [Related]
9. [Cellular immune responses of recombinant hepatitis B (rHB) vaccine and HBsAG derived from Hansenula polymorpha cells].
Hu ZY; He P; Zhang R; Fang X; Zhu FC; Qiu SH; Li HM; Wang H; Liang ZL; Zhuang H
Zhonghua Liu Xing Bing Xue Za Zhi; 2008 Jul; 29(7):706-11. PubMed ID: 19031766
[TBL] [Abstract][Full Text] [Related]
10. [Antibody reaction to immunization with different recombinant hepatitis B vaccine in primary school children].
Liang Z; Li C; Jing Q
Zhonghua Yu Fang Yi Xue Za Zhi; 1998 May; 32(3):165-7. PubMed ID: 10322792
[TBL] [Abstract][Full Text] [Related]
11. Immune response to hepatitis B vaccine in infants and newborns: control trial in an endemic area (Senegal).
Coursaget P; Deciron F; Tortey E; Barin F; Chiron JP; Yvonnet B; Diouf C; Denis F; Diop-Mar I; Correa P
IARC Sci Publ; 1984; (63):319-35. PubMed ID: 6242150
[TBL] [Abstract][Full Text] [Related]
12. Immune response induced by a different combined immunization of HBsAg vaccine.
Wu T; Chen M; Ou SH; Cheng T; Zhang J; Xia NS
Intervirology; 2007; 50(5):336-40. PubMed ID: 17700028
[TBL] [Abstract][Full Text] [Related]
13. [The study about immune response to Balb/c mice inoculated with hepatitis B virus DNA vaccine pCI/S2S].
He X; Zhao LS; Zhou TY; He F; Jiang N
Sichuan Da Xue Xue Bao Yi Xue Ban; 2007 Nov; 38(6):945-8. PubMed ID: 18095592
[TBL] [Abstract][Full Text] [Related]
14. [Suppression of the antigen-specific T cell immune response by co-immunization with the HBV DNA vaccine and recombinant HBsAg].
Du X; Wang J; Kang Y; Xiao W; Zhao G; Wang B
Wei Sheng Wu Xue Bao; 2009 Jul; 49(7):938-42. PubMed ID: 19873759
[TBL] [Abstract][Full Text] [Related]
15. [Reciprocal priming-boosting role of HBsAg and DNA vaccines].
Zhou Z; Chen WS; Zhang HH; Yao JL
Zhonghua Gan Zang Bing Za Zhi; 2003 Apr; 11(4):212-4. PubMed ID: 12716517
[TBL] [Abstract][Full Text] [Related]
16. Persistence of protection against hepatitis B virus infection among adolescents vaccinated with recombinant hepatitis B vaccine beginning at birth: a 15-year follow-up study.
Bialek SR; Bower WA; Novak R; Helgenberger L; Auerbach SB; Williams IT; Bell BP
Pediatr Infect Dis J; 2008 Oct; 27(10):881-5. PubMed ID: 18756185
[TBL] [Abstract][Full Text] [Related]
17. Comparison of a bacteriophage-delivered DNA vaccine and a commercially available recombinant protein vaccine against hepatitis B.
Clark JR; Bartley K; Jepson CD; Craik V; March JB
FEMS Immunol Med Microbiol; 2011 Mar; 61(2):197-204. PubMed ID: 21204995
[TBL] [Abstract][Full Text] [Related]
18. [Safety and immunogenicity of Bilive combined hepatitis A and B vaccine].
Zhao YL; Chen YG; Li J; Han GX; Tian C; Liang JL; Li G; Wang ZG; Zhu YG; Tian ZN; Zhang HY; Wan ZJ; Liang ZL; Bi SL
Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Jun; 25(6):470-3. PubMed ID: 15231119
[TBL] [Abstract][Full Text] [Related]
19. Robust gammadelta+ T cell expansion in infants immunized at birth with BCG vaccine.
Mazzola TN; Da Silva MT; Moreno YM; Lima SC; Carniel EF; Morcillo AM; Antonio MA; Zanolli ML; Netto AA; Blotta MH; Raw I; Vilela MM
Vaccine; 2007 Aug; 25(34):6313-20. PubMed ID: 17643559
[TBL] [Abstract][Full Text] [Related]
20. Intramuscular versus low-dose intradermal hepatitis B vaccine. Assessment by humoral and cellular immune response to hepatitis B surface antigen.
Frazer IH; Jones B; Dimitrakakis M; Mackay IR
Med J Aust; 1987 Mar; 146(5):242-5. PubMed ID: 2950303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
